NephroDI Therapeutics Announces Investment by Sound Bioventures to Accelerate Development of NDI-5001 as a Potential First-in-Class Therapy for Pediatric Orphan Kidney Disease
20 juin 2024 07h00 HE
|
NephroDI Therapeutics
New funding to take NDI-5001 into and through clinical proof of concept in Congenital Nephrogenic Diabetes Insipidus (NDI)New investment complements previously announced strategic corporate...
Sound Bioventures expands portfolio with new investment in US company NephroDI Therapeutics to accelerate development of NDI-5001 for pediatric orphan kidney disease
20 juin 2024 07h00 HE
|
Sound Bioventures
New funding will accelerate NephroDI’s asset, NDI-5001, into and through clinical proof of concept in Congenital Nephrogenic Diabetes Insipidus (NDI)New investment complements NephroDI’s previously...
Global Urology Laser Market Analysis Report 2024: Market Set to Surpass $1.8 Billion by 2031
31 mai 2024 04h03 HE
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Global Urology Laser Market Size, Share & Trends Analysis Report By Laser Type (Holmium Laser System, Thulium Laser System, Diode Laser System, and...
Global Urology Supplements Market Report 2024, Featuring Theralogix, Nature's Bounty, Solaray, Puritan's Pride, Schiff Nutrition, Biotexlife, MegaFood, Azo Health, Now Foods and Barleans
16 mai 2024 10h07 HE
|
Research and Markets
Dublin, May 16, 2024 (GLOBE NEWSWIRE) -- The "Global Urology Supplements Market" report has been added to ResearchAndMarkets.com's offering.The global urology supplements market size was estimated...
Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH
07 mai 2024 06h30 HE
|
Teleflex Incorporated
WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a global leader in medical technologies, today announced the presentation of new research findings from the 2024...
Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual Meeting
01 mai 2024 06h30 HE
|
Teleflex Incorporated
Highlights include two head-to-head randomized clinical trials (RCT) data presentations of UroLift™ System vs. other modalities to treat benign prostatic hyperplasia (BPH) -Additional studies examine...
Global Urology Supplements Market Trends Analysis Report 2024-2030: Asia Pacific Emerges as Dominant Force, Multi-Ingredient Supplements Lead
30 avr. 2024 05h36 HE
|
Research and Markets
Dublin, April 30, 2024 (GLOBE NEWSWIRE) -- The "Global Urology Supplements Market Size, Share & Trends Analysis Report by Type (Multi-ingredient, Single Ingredient), Application (Urinary Tract...
Global Portable Ultrasound Market Analysis Report 2024-2031: Use of Artificial Intelligence in Portable Ultrasound Devices and Emergence of Wearable Ultrasound Devices Gaining Momentum
18 avr. 2024 07h23 HE
|
Research and Markets
Dublin, April 18, 2024 (GLOBE NEWSWIRE) -- The "Portable Ultrasound Market by Product (POCUS, Handheld Ultrasound, Transducer, Gels), Technology (2D, 3D, 4D, Doppler), Display, Application (Breast...
Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types
02 avr. 2024 06h30 HE
|
Teleflex Incorporated
WAYNE, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the upcoming full market release of the Advanced...
Amber Therapeutics announces positive preliminary results from its first-in-human investigation of Amber-UI, its new adaptive implanted pudendal neuromodulation system for urinary incontinence
27 févr. 2024 09h00 HE
|
Amber Therapeutics
Key initial results from AURA-2 study highlight good safety and scalability of Amber-UI therapy A strong efficacy signal was seen in the form of complete resolution of incontinence episodes six months...